Targacept Reports Third Quarter 2012 Financial Results

[at noodls] – Winston-Salem, North Carolina November 06, 2012 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeuticsâ„¢, today reported its financial results for the … more

View todays social media effects on TRGT

View the latest stocks trending across Twitter. Click to view dashboard